NECC Pharmaceutical Case
Identification of Victims in Investigation of the New England Compounding CenterBetween approximately May and September, 2012, the New England Compounding Center (NECC) distributed three lots of preservative-free methylprednisolone acetate (MPA) to approximately 76 out-patient surgery centers in 20 different states. The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), continues to investigate and monitor a multistate outbreak of fungal meningitis and other infections among patients who received contaminated preservative-free MPA steroid injections from these three lots. The FBI, the FDA’s Office of Criminal Investigations, and other federal agencies opened a criminal investigation of NECC in October 2012. The FBI is concerned about the devastating impact the outbreak has had on victims and their families. Providing information and assistance to victims is an important part of our work. If you or a family member were a victim of the fungal meningitis outbreak, we request you submit the information identified below. For more information, see http://www.fbi.gov/stats-services/victim_assistance/seeking-victim-information/identifying-victims-in-the-investigation-of-new-england-compounding-center.
Thank you for completing this questionnaire. Please keep copies of all of your medical records.